FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
Meta urged by state AGs to regulate weight loss drug ads
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound
Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight…
Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks…
Mutual mistrust: FDA staff wary as Høeg becomes top drug regulator
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…
Eli Lilly’s weight loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
RFK Jr.’s vaccine panel to vote on hepatitis B shot for babies
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. looks on as he attends a press…
FDA removes Office of Nonprescription Drugs Director Theresa Michele
WASHINGTON — The Food and Drug Administration removed the longtime director of the office of over-the-counter drugs from…